Larimar Therapeutics
LRMR
LRMR
116 hedge funds and large institutions have $180M invested in Larimar Therapeutics in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
+13
Holders Change %
+12.62%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
30
Increased
43
Reduced
23
Closed
17
Calls
$14.1M
Puts
$347K
Net Calls
+$13.8M
Net Calls Change
+$13.8M
Top Buyers
| 1 |
Millennium Management
New York
|
+$8.62M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$6.35M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.61M |
| 4 |
Two Sigma Advisers
New York
|
+$2.18M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$1.99M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$13.1M |
| 2 |
Goldman Sachs
New York
|
-$7.34M |
| 3 |
Renaissance Technologies
New York
|
-$1.19M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$762K |
| 5 |
Morgan Stanley
New York
|
-$700K |
